Potential attenuation of fibrinolysis by growth factors released from platelets and their pharmacologic implications
- 1 June 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (20), 1505-1511
- https://doi.org/10.1016/0002-9149(89)90016-7
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.JCI Insight, 1988
- cDNA cloning and expression in E. coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cellFEBS Letters, 1987
- The biology of platelet-derived growth factorCell, 1986
- Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells.The Journal of cell biology, 1986
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.JCI Insight, 1983
- The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen productionJournal of Immunological Methods, 1982
- “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein AAnalytical Biochemistry, 1981
- Human Hepatocellular Carcinoma Cell Lines Secrete the Major Plasma Proteins and Hepatitis B Surface AntigenScience, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970